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Abstract: Recent theoretical accounts of addiction have acknowledged that addiction to 
substances and behaviors share inherent similarities (eg, insensitivity to future consequences and 
self-regulatory deficits). This recognition is corroborated by inquiries into the neurobiological 
correlates of addiction, which has indicated that different manifestations of addictive pathology 
share common neural mechanisms. This review of the literature will explore the feasibility of 
the somatic marker hypothesis as a unifying explanatory framework of the decision-making 
deficits that are believed to be involved in addiction development and maintenance. The somatic 
marker hypothesis provides a neuroanatomical and cognitive framework of decision making, 
which posits that decisional processes are biased toward long-term prospects by emotional 
marker signals engendered by a neuronal architecture comprising both cortical and subcortical 
circuits. Addicts display markedly impulsive and compulsive behavioral patterns that might 
be understood as manifestations of decision-making processes that fail to take into account 
the long-term consequences of actions. Evidence demonstrates that substance dependence, 
pathological gambling, and Internet addiction are characterized by structural and functional 
abnormalities in neural regions, as outlined by the somatic marker hypothesis. Furthermore, 
both substance dependents and behavioral addicts show similar impairments on a measure of 
decision making that is sensitive to somatic marker functioning. The decision-making deficits 
that characterize addiction might exist a priori to addiction development; however, they may be 
worsened by ingestion of substances with neurotoxic properties. It is concluded that the somatic 
marker model of addiction contributes a plausible account of the underlying neurobiology of 
decision-making deficits in addictive disorders that is supported by the current neuroimaging 
and behavioral evidence. Implications for future research are outlined.
Keywords: addiction, somatic marker hypothesis, decision making, emotion, Iowa Gam-
bling Task
Introduction
Addiction is characterized as a condition in which neural systems involved in moti-
vation and behavioral control promote self-regulatory failure that persists in the face 
of increasing negative consequences.1 The component model of addiction posits that 
the addiction state involves increased salience attribution to the addictive object, 
mood modification, development of tolerance, withdrawal, internal and external 
conflict, and relapse.2 This conceptualization implies that addiction is not confined 
to chemical substances, but can also involve behaviors like excessive gambling and 
Internet use. Recognition of the behavioral similarities across addictions coincides 
with increasing evidence indicating that chemical and nonchemical addictions might 
share common neural mechanisms.3–5 Impulsive and compulsive behavior in addiction 
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have been associated with defective decision making.6 
A better understanding of the abnormal decisional processes 
observed in various kinds of addiction has therefore come 
into focus of research on development and maintenance of 
addiction. The somatic marker hypothesis (SMH) provides 
a theoretical framework for an explanation of dysfunctional 
decision-making patterns in addicts. This review provides an 
overview on the current state of research on decision making 
in addiction with a particular focus on the role of somatic 
marker theory’s contributions.
The decision-making deficits in addiction are comparable 
to those seen in patients with prefrontal cortical lesions – a 
marked obliviousness to future consequences of decisions and 
deficient experience-based learning.7 This observation and 
supporting physiological and anatomical assessments have 
led to the notion that pathophysiology in the prefrontal cortex 
could be an important neural underpinning of addiction.8–10 
Decisional outcomes following affective–cognitive integra-
tion in prefrontal areas are influenced by afferent connections 
to limbic system areas. The SMH provides a system-level 
framework describing how decision-making processes are 
influenced by emotional signals arising from bioregulatory 
changes that express themselves in both brain and body.11,12 
The theory developed from studies of the decision-making 
deficits of patients with lesions in the ventromedial pre-
frontal cortex (vmPFC).13,14 The SMH echoes and extends 
the Jamesian account of peripheral feedback, positing that 
emotional biasing signals from the periphery guide the 
decision-making process toward long-term prospects in situa-
tions characterized by complexity and uncertainty.15  Evidence 
indicates that the normal operation of somatic markers is 
dependent upon various structures involved in expressing 
emotions in the periphery, such as the vmPFC and amygdala, 
as well as structures implicated in the central representation of 
the changes taking place in the body proper (somatosensory 
cortex, insular cortex, basal ganglia, cingulate cortex).16–18
The empirical support for the SMH has largely been 
derived from an affective decision-making paradigm aimed 
at mimicking real life decision making in the way it factors 
uncertainty, reward, and punishment – the Iowa Gambling 
Task (IGT).11 Bechara et al19 suggested a correlation between 
successful performance and heightened skin conductance 
responses (SCR) anticipating unconscious disadvantageous 
decisions on this task.19–21 These anticipative SCRs have been 
interpreted as an index of somatic marker signals, and are 
absent in patients with lesions in the vmPFC. Interestingly, 
the paradigm has been used to explore decision making in 
various clinical populations and several studies indicate that 
somatic marker deficits might underlie a plethora of clini-
cal manifestations of impaired decision making, including 
those seen in drug addiction,22 psychopathy,23,24 anxiety,25 
obsessive–compulsive disorder,26 and panic disorder.27
Increasing evidence indicates that addiction is charac-
terized by a defect in the somatic marker mechanism that 
normally supports the selection of adaptive behavior, giving 
rise to inappropriate emotional markers of the anticipated 
negative consequences of future action, thus promoting self-
regulatory failure.10,28 Previous literature reviews exploring 
the relationship between somatic markers and addiction have 
implied that the SMH can explain dysfunctional decision 
making in both substance and behavioral forms of addiction, 
such as pathological gambling and Internet addiction.7,10,29,30 
While previous literature reviewed findings supporting the 
model’s ability to explain dysfunctional decision making in 
drug addiction, it does not provide conclusive evidence for 
whether its predictions hold true for behavioral addictions as 
well. Moreover, the etiology of the somatic marker defects 
has not been elaborated upon; further research is required to 
determine whether the defective somatic marker signaling 
system thought to be involved in addiction is a premorbid 
vulnerability factor or a result of addictive behavior.
First, a brief overview of the current understanding 
of the neurobiology of somatic marker signaling will be 
provided. Thereafter, the neurophysiological and neurocog-
nitive evidence pertinent to predictions from the somatic 
marker model of addiction will be reviewed, and the model’s 
applicability to defective decision making in addiction will 
be critically appraised. The scope will be limited to drug 
addiction, pathological gambling, and Internet addiction, 
as these represent the addictive disorders that have received 
the most research attention. Finally, the review will discuss 
the etiology of somatic marker defects and the possibility 
of a diathetic vulnerability for addiction from the defective 
decision making that results from a dysfunctional somatic 
marker signaling system.
Neurobiological correlates  
of somatic marker signaling
The SMH posits that the neural embodiment of somatic state 
information in relation to situational contingencies holds 
biasing properties capable of guiding the decision-making 
process via reactivation of somatic states previously paired 
with an option–outcome pair (overviews have been previously 
published15,16). The SMH distinguishes between two differ-
ent triggers of somatic state activation, each associated with 
distinct neural substrates.31 Primary inducers refer to innate 
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or learned stimuli that are associated with automatic somatic 
(emotional) responses, mediated by subcortical structures 
involved in emotional processing, where the amygdala is 
an essential structure. Secondary inducers refer to cognitive 
stimuli generated from thoughts and memories of an actual 
or hypothetical emotional event – eg, the memory of taking 
a drug or the thoughts about taking the drug in the future. 
While operating via the same somatic effector structures in 
the brain stem and hypothalamic area that the amygdala does 
in the case of primary induction, induction from secondary 
inducers is associated with higher-order associative areas in 
the vmPFC, which are capable of encoding and reactivating 
somatic states associated with a particular option–outcome 
pair.16 Moreover, once a dispositional representation is estab-
lished, thus allowing secondary induction, the reactivation 
may proceed as an intracerebral replay of the changes in the 
soma, via the as-if loop mechanism that bypasses the body 
proper altogether.32
Both the vmPFC and the amygdala are richly connected 
to somatic effector structures in hypothalamic and brain stem 
nuclei that are capable of playing out bioregulatory changes 
in the body proper – eg, they initiate a somatic marker. 
These emotional changes are engendered in the body via 
the spinal cord, cranial nerves, and endocrine signaling. The 
afferent projections of the ensuing changes are represented 
in somatotopically-organized regions. The somatosensory 
cortices in the parietal lobe (SI and SII) and the insular cor-
tices monitor interoceptive information continuously,33 and 
especially the anterior part of the insular cortex is believed to 
be a key neural underpinning for the conscious experience of 
the body and the emotions of which it serves as a theater.18,34 
Indeed, neuroimaging studies have shown that the strength 
of insular activity correlates with both perceived emotional 
intensity and accuracy in interoceptive judgments.18,35 
Moreover, various studies have demonstrated associations 
between insular activation and decisional outcomes. For 
example, Werner et al36 reported that insular activation is 
predictive of successful intuitive decision making. Related, 
high interoceptive accuracy is positively associated with 
higher susceptibility to emotional biases in an emotionally 
framed decision-making task37 and with detrimental effects 
of dysfunctionally processed interoceptive biases on decision 
making in patients with panic disorder.27 These findings and 
strong evidence on the neuronal correlates of interoceptive 
accuracy identified in the anterior insular cortex18 strengthen 
previous suggestions that this region is an integral structure 
for the behavioral effects of somatic markers. The role of 
the insular cortex in somatic marker biasing actions is fur-
ther corroborated by lesion studies linking damage to this 
structure to distinct decision-making deficits, especially an 
insensitivity to value differences among response options.38,39 
Thus, impaired functioning of the insular cortex may reduce 
the individual’s ability to determine the value of response 
options due to inefficient utilization of peripheral changes 
that options of emotional salience typically induce.
The biasing actions of somatic markers are not restricted 
to the immediate selection of adaptive behavioral programs. 
Somatic markers are hypothesized to assist overt reason-
ing processes where they amplify some response options 
over others, in such a way that more executive resources 
are dedicated to these options.16 This assumption is consis-
tent with the elaborate connections between regions of the 
somatic marker system, especially the vmPFC, and regions 
involved in working memory and conflict resolution, such 
as the dorsolateral prefrontal cortex (dlPFC) and the anterior 
cingulate cortex.40,41 Moreover, studies employing executive 
load paradigms combined with tasks measuring decision 
making suggest that regions involved in mediating executive 
resources, particularly working memory, are necessary, but 
not sufficient, for the overt guidance of behavior through 
somatic marker biasing actions.42,43 Furthermore, it is 
assumed that somatic markers can bias behavior implicitly – 
that is, outside conscious awareness – through connections to 
regions in the basal ganglia, especially the striatum.10 This is 
of special interest in the context of addiction, with compel-
ling evidence suggesting that increased dopamine transmis-
sion from the mesolimbic dopamine system to the ventral 
striatum drives incentive motivational processes outside 
its adaptive range in addiction, resulting in an attentional 
bias toward and increased wanting of the desired object.44,45 
Thus, there may be an interaction at the level of the striatum 
between dopamine-driven processes involved in incentive 
motivation and affective–cognitive signals from prefrontal 
cortical circuits.
Neurochemical mediation  
of somatic state influence  
on behavior and cognition
Advances in neuropharmacological research have begun to 
unravel how neurochemical transmitter substances influence 
behavior and cognition. Particularly, the monoamines have 
received considerable attention and are believed to play 
important roles in various cognitive processes, including 
decision making.46 The monoamine neurotransmitters have 
also been a major focus in the study of psychopathology, 
including addiction,47 and substantial evidence favors a 
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causal role for these neurochemicals in many psycho-
pathological conditions. While the precise role of these 
neuromodulating substances in decision-making processes 
remains unknown, there is evidence to indicate that the 
biasing properties of somatic markers are due, in large part, 
to changes in the release of these transmitter substances 
in various parts of the brain implicated in cognitive and 
emotional processing – eg, the vmPFC, amygdala, insular 
cortex, and striatum.16
Accumulating evidence suggests that the serotonergic 
system is an integral part of adaptive decision making and 
might play a central role in the biasing properties of somatic 
markers.48,49 Rogers et al50 found evidence of an association 
between low levels of serotonin (5-HT), induced by dietary 
challenge, and poor performance on a paradigm sensitive to 
orbitofrontal/vmPFC functioning. Moreover, low 5-HT levels 
have been consistently associated with an increased tendency 
toward temporal discounting51,52 and impulsive behavior,53 
both of which are clearly involved in addictive behavior. The 
dopaminergic system has also been implicated in affective 
decision making, with evidence demonstrating an association 
between lowered levels of dopamine and impaired perfor-
mance on the IGT.54 Specifically, reduced levels of dopamine 
seem to interfere with performance in the first part of the 
task, when the decision-making process is guided by implicit 
knowledge of the task contingencies. In contrast, it has been 
found that manipulations of the serotonergic system affect the 
latter part of the task.55 Thus, dopamine and 5-HT might be 
linked to different modes of decision making, with dopamine 
primarily involved in decision making under ambiguity and 
5-HT in decision making under risk.
Recent evidence has indicated that the efficiency of the 
somatic marker system is influenced by genetic variations 
related to serotonergic and dopaminergic functioning. For 
example, Miu et al49 found that individuals homozygous 
for an allele associated with low efficiency of the serotonin 
transporter (5-HTT; the molecule involved in the synaptic 
reuptake of 5-HT) displayed better performance and stronger 
SCRs preceding disadvantageous selections on the IGT. This 
study indicates a facilitative effect of the allelic variation 
associated with the decreased reuptake of 5-HT. However, 
other studies of the association between 5-HTT alleles and 
IGT performance have yielded conflicting findings.56–59 With 
regards to the dopamine system, Roussos et al60 investigated 
the effects of allelic variations on the catechol-O-methyl-
transferase (COMT) gene on decision-making performance, 
and found an association between the allele conferring 
more efficient enzymatic degradation of catecholamines 
and adaptive decision making. This might seem inconsistent 
with the results from the study by Sevy et al54 mentioned 
earlier; however, enzymatic degradation of dopamine 
and dopamine reduction achieved by dietary challenge is 
not directly comparable. There is probably an optimal level 
of dopamine transmission associated with adaptive affective 
decision making.
Finally, the brain-derived neurotrophic factor (BDNF) 
gene has been linked to affective decision making. For 
example, Kang et al61 found an association between the 
Met allele on the BDNF gene and reduced performance on 
the latter trials of the IGT. BDNF has been widely impli-
cated in synaptic plasticity62 and might thus be involved 
in the encoding of option–outcome pairs. Consequently, 
the BDNF gene might influence the efficiency of which 
emotional valence – ie, a somatic marker – is coupled 
with mental representations in neural circuits involved in 
somatic marker functions.
In sum, evidence indicates that 5-HT and dopamine 
play central and distinct roles in affective decision making. 
However, their precise roles remain unclear and genetic 
association studies into allelic variations that influence 
serotonergic activity have yielded conflicting findings that 
are not easily reconciled. Complex gene–environment and 
gene-by-gene interactions are likely to be involved. Thus, 
complex interactions between transmitter systems probably 
account for the final effect of somatic markers on decisional 
processes.
Defective somatic marker  
signaling in addiction
Both addicts and patients with orbitofrontal lesions display 
insensitivity to future consequences, difficulties in behavioral 
regulation, and impulse control deficits.7,32,53,63,64 The SMH 
has the potential to contribute to an understanding of these 
dysfunctional self-regulatory mechanisms in terms of the 
notion of an affective forecasting function that interacts 
with executive functions in behavioral selection.10 While 
defective somatic marker signaling could be involved in the 
maintenance of addictive behavior, the somatic marker model 
of addiction also assumes that addicts and nonaddicts differ 
in neural systems related to decision making and somatic 
state activation even before the addiction is established.7 
Thus, in addition to biasing the individual to preserve mal-
adaptive compulsive behavior, somatic marker defects are 
hypothesized to convey increased susceptibility to impulsive 
behavior and the development of addictive disorders. This 
diathetic assumptions imply that somatic marker defects 
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are an endophenotypic biomarker for addictive behavior – eg, 
impulsion and compulsion.
Imbalanced dual processing:  
the impulsive versus the  
reflective system
The somatic marker model of addiction envisions addiction as 
a state characterized by an imbalance between an impulsive 
system that mediates the incentive motivational properties 
of emotionally competent stimuli, and a reflective system 
responsible for the control of impulses and the pursuit of long-
term goals.65 This notion is compatible with the influential 
dual-process conceptualization of decision making.66–70
The impulsive system corresponds to neural circuits 
involved in appetitive approach behaviors. The amygdala 
and ventral striatum are believed to be integral structures 
in this system. For example, neurons in the ventral striatum 
are highly responsive to natural rewards, and in the case of 
addiction, they fire vigorously in response to the addictive 
object.71 Moreover, it has been shown that excitatory input 
from the basolateral amygdala to the nucleus accumbens 
determines the ensuing reward-seeking behavior in animal 
models.72,73 The impulsive system responds to emotionally 
competent stimuli with bioregulatory changes through 
its extensive connections with the subcortical effector 
structures.74 The ensuing changes bias the organism toward 
the rewarding stimulus – eg, a positive somatic marker is 
engaged for the stimulus – which may take on secondary 
inducer properties through the reflective system. The somatic 
marker model of addiction posits that the impulsive system 
may be dominant in addiction, a condition characterized 
by excessive emotional reactivity toward the addictive 
object.
The reflective system is associated with deliberate and 
goal-directed behavior, and is thought to correspond to 
regions of the prefrontal cortex and cingulate cortex. The 
system is dependent upon the functioning of neural circuits 
associated with cool executive functions like working mem-
ory and response inhibition, functions mediated primarily 
by the dorsolateral and ventrolateral sectors of the PFC, as 
well as hot executive functions like the secondary induction 
of somatic states and conflict resolution mediated by the 
medial PFC and anterior cingulate cortex.16,75 The operations 
of the reflective system are critical for decision making that 
is consistent with long-term prospects, and it is thought to be 
dysfunctional in disorders of addiction, rendering the system 
incapable of regulating the basic impulses associated with 
the addictive object.10
A neural structure gaining increased interest in recent 
years and considered to influence the efficiency of the two 
systems is the insular cortex.76,77 The insular cortex has 
been outlined as a structure capable of holding representa-
tions of somatic markers online to influence behavior and 
cognition, thus providing the basis for subjective feelings 
of interoceptive signals.18,36 The insular cortex may be 
involved in translating the homeostatic signals related 
to the condition of the body in withdrawal states into the 
subjective experience of craving. Indeed, a recent study 
of patients having suffered strokes in the insular region 
indicates that damage to this structure literally wipes out 
addiction to nicotine, a finding that implicates the insular 
cortex in the maintenance of addiction.78 The reduction in 
nicotine consumption is hypothesized to result from a fail-
ure in translating interoceptive information into conscious 
feelings, thus eliminating craving. Evidence indicates that 
the reduction of smoking behavior is even more pronounced 
when lesions include parts of the basal ganglia, thus damag-
ing both homeostatic and impulsive circuitry.79 The insular 
cortex may serve a catalytic function for the impulsive 
system, amplifying the capacity of the addictive objects to 
trigger the system in withdrawal states. Moreover, insular 
projections may subvert or functionally hijack the reflec-
tive system in pursuit of the addictive object.80 This idea is 
compatible with the neuroanatomical evidence of the insular 
cortex’s bidirectional connections to both the orbitofron-
tal cortex (OFC)81 and the amygdala.82 Thus, a primarily 
insular-based homeostatic system could influence the dual 
systems in such a way that emotional signals initiated by 
these reward-driven circuits bias the addict toward the 
desired object.
Neurophysiological abnormalities  
in addiction
Neurophysiological irregularities found in addicts comprise 
areas involved in the somatic marker system, and which have 
been associated with dysfunctional decision making. Several 
abnormalities have been uncovered in regions correspond-
ing to the reflective system in drug addiction. A consistent 
finding is reduced gray83 and white84 matter integrity and 
abnormal activation85 of the OFC. Decreased gray matter in 
the OFC has been found in various samples of drug addicts, 
including alcohol,86 heroin,87 cocaine,88 methamphetamine,89 
nicotine,90 and cannabinoid addiction.91 Furthermore, lower 
gray matter density has been reported in the dlPFC87 and the 
anterior cingulate cortex88,92,93 in various drug addictions, as 
compared to healthy controls.
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Similar findings have been uncovered in samples of 
behavioral addicts, although the evidence is mixed. For 
example, behavioral paradigms sensitive to orbitofrontal 
functioning (eg, the IGT) have indicated that the pathophysio-
logy in the orbitofrontal/vmPFC region is related to patho-
logical gambling.94 However, few studies have explored the 
structural correlates of pathological gambling, and those 
studies that have examined the morphological correlates of 
this disorder have failed to identify gross structural abnor-
malities in the OFC or associated regions of the frontal 
lobe.95 However, one study, in fact, found that a sample of 
pathological gamblers had increased gray matter density in 
the right OFC and the right ventral striatal area.96 Notably, 
it has also been found that pathological gamblers display 
increased functional connectivity between the right PFC 
and right ventral striatum.97 Studies of white matter integ-
rity in pathological gambling have identified abnormalities 
that may affect frontal lobe functioning.98,99 These studies 
have demonstrated white matter microstructural abnormali-
ties in the anterior corpus callosum, which contains tracts 
that are critical for signal transmission between the frontal 
hemispheres. These findings corroborate an early finding 
by Goldstein et al,100 suggesting that pathological gamblers 
displayed electroencephalographic activity indicating diffi-
culties in shifting hemispheric activity in accordance with the 
shifts between tasks typically associated with either right or 
left hemispheric activation. Thus, abnormal communication 
between the different components of the reflective system 
(eg, the vmPFC, dlPFC, and anterior cingulate cortex) may 
be associated with dysfunction in this system in pathological 
gambling, which may result in a reduced ability to initiate 
prospective somatic markers to guide decisional processes 
toward long-term outcomes.
Unlike pathological gambling, studies into the mor-
phological correlates of Internet addiction have uncovered 
widespread structural anomalies in the brain regions impli-
cated in the reflective system. For example, various studies 
report volume reductions in the OFC, particularly in the right 
hemisphere.101–104 This hemispheric asymmetry is notable, 
as Bechara and Damasio16 indicated that somatic marker 
functions are somewhat lateralized to the right hemisphere. 
Furthermore, volume reductions have been reported in the 
bilateral dlPFC,104 left anterior cingulate cortex,104,105 and 
left posterior cingulate cortex105 in samples of Internet 
addicts. Moreover, studies employing structural imaging 
techniques have identified white matter abnormalities similar 
to those seen in drug addiction and pathological gambling. 
For example, a study by Lin et al106 revealed widespread 
white matter abnormalities in the OFC, anterior corpus cal-
losum, cingulum, and the corona radiata. Similar findings 
were reported by Weng et al,103 who found extensive white 
matter reductions in the frontal lobe and the anterior corpus 
callosum. A recent study by Lin et al107 also found frontal lobe 
white matter deficits in a larger sample of Internet addicts, 
primarily located to the inferior frontal gyrus and the anterior 
cingulate cortex. These studies indicate that similar deficits in 
prefrontal cortical control systems may be shared by various 
addictions, and that these deficits may result in a pathological 
state characterized by increasing addiction-related behavior 
in the face of negative personal and social consequences 
due to a dysfunction in the system responsible for weighing 
the consequences of actions against their immediate benefit, 
and they may generate somatic states on the basis of these 
prospects.
In the sense of dual-process models on health behavior,108 
a defective reflective system may leave the addict at the mercy 
of basic impulses generated by the impulsive system. These 
basic impulses may be triggered either by external (eg, drug 
cue, gambling cue, Internet cue) or internal (eg, thoughts 
or memories of the addictive object) stimuli. According to 
the somatic marker model of addiction, the trigger stimulus 
will cause a cascade of neural responses, some of which are 
involved in generating a somatic state that is relayed to struc-
tures involved in body mapping and homeostatic regulation 
(eg, insular cortex); these structures will then translate the 
somatic state information into a feeling (eg, urge or desire), 
which biases the addict toward the addictive object.10
Particularly, the ventral striatum and amygdala have 
emerged as important structures for the mediation of moti-
vational properties of addiction-related stimuli.109,110 Indeed, 
neuroimaging studies have identified that these structures 
are consistently activated by cue-induction paradigms in 
addiction samples.111–113 In addition, it seems that addiction 
is characterized by a blunted reward circuitry response to 
nonaddiction cues pertaining to natural rewards like food 
and sex.114–116 The dominant view of this imbalanced process-
ing of addiction versus nonaddiction cues is Robinson and 
Berridges’ incentive sensitization theory,44,45 which posits 
that addiction is a result of abnormal salience attribution to 
addiction-related objects at the level of dopamine-innervated 
regions involved in the processing of reward (eg, the ventral 
striatum). Although the evidence for this position in the 
case of drug addiction seems to be convincing, it remains 
controversial whether it applies to nonchemical addictions. 
For example, recent studies have found that pathological 
gamblers do not display increased levels of dopamine release 
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during the IGT.117,118 However, it was found that dopamine 
release was associated with decision-making deficits among 
pathological gamblers, in contrast to normal controls, for 
whom it was correlated with increased performance.118 
This is notable, because it indicates that different neural 
processes are at play in the two groups, despite similar levels 
of dopamine release. It can be speculated that the addicted 
population displays poor performance because of a deficit in 
reflective system modulation of the impulsive system, which 
biases them against larger short-term rewards; even though 
these short-term rewards are associated with larger long-term 
losses. A recent neuroimaging study, however, identified 
that pathological gamblers had increased functional con-
nectivity between the amygdala and ventral striatum during 
a value-based decision-making task.119 Increased functional 
connectivity between reward-related circuitry coupled with 
decreased functional connectivity between reflective circuits 
has been observed in samples of drug addicts.120 These 
findings support the notion of addiction as a state where 
addiction-related stimuli have an increased potential to elicit 
approach behavior through an impulsive system that is both 
overactive and unregulated.
The impulsive system is richly connected to effector 
structures at the level of the hypothalamus and brain stem. 
Through these connections, motivational objects have the 
capacity to change the somatic landscape. These changes 
are perceived by structures involved in body mapping and 
homeostatic regulation that give rise to conscious feelings of 
desire. Evidence indicates that the insular cortex is the main 
substrate in this process of somatic information translation. 
Recent interest in this structure in addiction research has 
resulted in evidence indicating maladaptive functioning of 
this system in addiction.77,121
Reduced gray matter volume has been reported in the 
insular cortex in both drug and behavioral addiction. For 
example, Franklin et al88 found decreased gray matter volume 
in the anterior insular cortex in a sample of cocaine addicts. 
Interestingly, these volume abnormalities did not correlate 
with the severity of the addiction, indicating that insula abnor-
malities may represent a premorbid vulnerability to addiction. 
Decreased gray matter volume in the insular cortex has also 
been reported for alcohol addicts.122 However, these volume 
reductions seem to be positively correlated with alcohol 
consumption, and preliminary evidence indicates that they 
reverse with abstinence.123 Although the few studies that have 
explored the structural correlates of pathological gambling 
have not reported morphological abnormalities in the insula, 
Internet addicts have been reported to display significant gray 
matter reductions in the insular region.103–105 One of these 
studies found that the reduction of volume correlated with 
scores on a measure of Internet addiction severity.103
Functional neuroimaging has shown that insular cortex 
activation to drug cues is increased in drug addicts relative 
to controls.124 Increased activity in the insular cortex has also 
been reported in pathological gamblers during exposure to 
gambling-related cues.112 Although increased insular activa-
tion would be predicted to occur among Internet addicts as 
well, studies of cue reactivity in this population have not 
observed increased insular activation to Internet stimuli. 
However, one study reported increased insular cortex activa-
tion at rest in Internet addiction.125 Some studies show that 
cue reactivity in the insular cortex is related to significant 
differences in clinical outcome variables in addiction. For 
example, Janes et al126 demonstrated that increased anterior 
insular cortex activation to smoking cues predicted slips 
among abstinent nicotine addicts, while Claus et al127 showed 
that increased insular activation was associated with addic-
tion severity in alcohol addiction. Furthermore, Tsurumi 
et al128 found that insular activation in a reward anticipation 
task was inversely related to the duration of illness among 
abstinent pathological gamblers. While this finding seems 
somewhat at odds with the finding reported earlier,112 we 
suggest that this discrepancy may be due to the nature of 
the task. Tsurumi et al128 used points instead of money as the 
incentive and, thus, the decrease in activation may due to the 
specificity in the reward responses mentioned earlier.116
In sum, the findings summarized here indicate that 
addictions, both drug and behavioral, are characterized by 
neural abnormalities in various regions of the brain involved 
in somatic marker functioning. Both structural and func-
tional abnormalities have been uncovered in the reflective, 
impulsive, and homeostatic system in addiction samples. 
Furthermore, there seems to be a substantial degree of 
overlap in neural abnormalities between various forms of 
addiction. This is in line with the diathetic assumption held 
by the somatic marker model, which states that addiction is 
characterized by neurocognitive deficits that exist a priori 
to the addiction as a vulnerability marker, and that these 
neurocognitive deficits are caused by abnormal functioning 
in the circuits that constitute the somatic marker system. 
However, the studies summarized here are cross-sectional; 
thus, causal conclusions are premature.
Decision making in addiction
As stated earlier, addiction is characterized by structural and 
functional abnormalities in regions implicated in cognitive 
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and emotional processing. These abnormalities may manifest 
themselves behaviorally in domains involving both rational 
and emotional decision making. The somatic marker model 
of addiction holds that addiction is a state where the reflective 
system is compromised, which can result in a failure to utilize 
emotional marker signals pertaining to long-term outcomes in 
decisional processes, and thus the impulsive system, operat-
ing without the restraints of the reflective system, may bias 
the addict to immediate rewards.10 This section will review 
behavioral evidence pertinent to this account. The scope will 
be limited to studies involving the IGT, as this paradigm 
is believed to be sensitive to the cognitive defects arising 
from somatic marker failure. Indeed, neuroimaging studies 
have demonstrated that successful performance of the IGT 
is correlated with activation of neural architecture outlined 
by the SMH.129
Studies employing the IGT in samples of drug addicts 
unequivocally demonstrate impaired affective decision-
making performance.22,130–133 This finding has emerged consis-
tently across samples comprising various drug addict groups. 
Notably, Bechara and Damasio22 found that the maladaptive 
decision-making performance was associated with attenuated 
SCRs preceding disadvantageous card selections relative to 
controls, supporting the notion of somatic marker failure. 
However, it was also observed that a significant number of 
the addicts in the sample performed the task successfully. 
The decomposition of task performance into blocks reveals 
differences in learning curves, and has thus been the focus 
of research on addiction and decision making. Drug addicts 
display a shallower learning curve in comparison to controls; 
however, this also indicates that the drug addicts do not suffer 
from a general myopia of the future, as is the case for vmPFC-
lesioned patients.22 Rather, this block-by-block analysis 
suggests that drug addicts are more driven by immediate 
outcomes, with a disproportional weighing of large rewards 
that could hamper learning of the task contingencies. In a 
follow-up study of the same sample, a reversed variant of the 
IGT was administered to test whether decreased performance 
was due to hyper-reactivity to reward or a general insensitiv-
ity to future consequences of actions. It was found that drug 
addicts could be subdivided into three groups according to 
their performance on the variant IGT131: 1) hyper-reactive to 
reward; 2) general insensitivity to future consequences; and 
3) no impairment. This finding indicates an equifinality in the 
sense that addiction can develop from the failure of different 
components of the somatic system in unison or independently 
of each other. Reflective system deficits can hamper the abil-
ity to utilize prospective somatic markers pertinent to nega-
tive future outcomes, while impulsive system hyper-reactivity 
can engender such a powerful approach-related signal that 
reflective processes are functionally overthrown. In line with 
this argument, Xiao et al134 demonstrated that suboptimal IGT 
performance in a sample of adolescent binge drinkers was 
associated with increased activation in the left amygdala and 
bilateral insular cortex, as well as decreased OFC activation 
relative to controls.
The IGT has also been used to investigate decision mak-
ing in pathological gambling, and the results are consistent 
with those obtained in substance addiction.135,136 However, 
few of these studies have included psychophysiological 
measurements. One exception is a study by Goudriaan et al,137 
which found that affective decision-making defects were 
associated with attenuated SCRs preceding disadvantageous 
card selection on the IGT. This psychophysiological profile 
during IGT performance is consistent with that observed 
in the study by Bechara and Damasio,22 and lends further 
support to the notion of abnormal somatic marker function-
ing in pathological gambling. Moreover, a recent functional 
magnetic resonance imaging study by Power et al138 showed 
that impaired IGT performance in pathological gambling is 
associated with increased activation of the impulsive circuitry 
(amygdala and striatum), but also of the OFC.
Few studies have explored affective decision making 
in Internet addiction with the IGT. We identified four stud-
ies,139–142 and the results are mixed. While some studies have 
indicated that Internet addicts display decision-making defi-
cits comparable to those reported in samples of drug addicts 
and pathological gamblers,139,140 others have indicated no 
impairment.141,142 However, the discrepancy in results may be, 
in part, due to the operational definitions of Internet addiction 
utilized. The study by Ko et al141 defined Internet addiction as 
Internet usage that surpasses 2 hours per day, while Metcalf 
and Pammer142 defined excessive Internet gaming (a form 
of Internet addiction) as 5 hours or more per week. Thus, it 
is likely that a substantial portion of the Internet addiction 
samples in these studies included participants that were not 
functionally impaired by their Internet use. It might be specu-
lated that more rigorous inclusion criteria would yield results 
that are more representative of the affective decision-making 
capabilities that characterize Internet addicts.
The studies reviewed here have all relied on the IGT 
as a measure of affective decision making. However, it is 
notable that the task has received criticism. Foremost, the 
task’s ability to capture affective decision-making capa-
bilities has been challenged. Specifically, it has been argued 
that the task’s reward/punishment schedule is cognitively 
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penetrable, and thus task performance can be driven by 
conscious knowledge.143 In light of recent evidence, this 
criticism seems partially justified, as Guillaume et al144 
demonstrated that differences in performance were related 
to conscious knowledge. However, task performance was 
also positively correlated with SCRs preceding disadvanta-
geous card selections, and these were not associated with 
conscious knowledge. This suggests that both explicit 
knowledge and somatic markers contribute independently 
to task performance. However, it has been suggested that 
the interpretation of the SCRs as reflecting somatic marker 
biasing actions are incorrect, and there is some evidence 
supporting this suggestion.145 This represents a challenge for 
the SMH and epitomizes that it still is an evolving theoretical 
framework requiring empirical validation.
The diathetic assumption: 
neurocognitive deficits as  
a predisposing factor
A major tenet of the somatic marker model of addiction 
is that neurocognitive deficits related to abnormal somatic 
marker functioning is premorbid and acts as a predisposing 
factor to addiction. However, the study of this hypothesis is 
complicated by the fact that drugs of abuse have neurotoxic 
properties.146,147 Assuming that different forms of addiction 
have a similar pathophysiological and neurocognitive funda-
ment, comparative studies of drug and behavioral addicts 
may dissociate the consequences of drug abuse from the 
neurocognitive deficits that are predisposing to addiction.
To dissociate the predisposing neurocognitive factors 
from drug-induced decrements in cognitive performance, 
Yan et al148 did a comparative study of heroin addicts and 
pathological gamblers where affective decision-making and 
working memory performance were tested. Their results 
indicated that affective decision-making defects are present 
in both disorders and are linked to years of abuse in heroin 
addiction, but not in pathological gambling. Working memory 
deficits were present only in heroin addiction. These results 
are similar to the ones obtained by Goudriaan et al149 in a 
comparison of alcohol addicts and pathological gambling. 
These studies suggest that affective decision-making capaci-
ties may represent a predisposing factor for addiction, and can 
be worsened and extended to other neurocognitive functions 
(eg, working memory) by the ingestion of substances with 
neurotoxic effects.
In support of the notion of affective decision-making 
capacity as a predisposing factor, Xiao et al150 showed that 
IGT score was a significant predictor of drinking behavior 
at a 1 year follow-up in a longitudinal study of Chinese 
adolescents. Similarly, IGT scores have been shown to be 
predictive of the development of smoking behaviors in an 
adolescent sample.151 These findings are corroborated by 
studies linking volumetric abnormalities in reflective circuits 
to future drug behavior. In one longitudinal study, it was found 
that smaller OFC volume at the age of 12 years predicted the 
initiation of cannabis use 4 years later.152 In a later publica-
tion, the same group reported that volumetric differences in 
the anterior cingulate cortex at the age of 12 years predicted 
problem drinking 4 years later.153 Moreover, Weiland et al154 
found an inverse association between scores on an assessment 
of early risk for substance abuse and frontal cortex volume 
in young adults. Thus, while there is strong evidence for 
neurotoxic effects on neural circuitry associated with drug 
use, subtle neural abnormalities in regions involved in the 
somatic marker system may already be present prior to drug 
use. These abnormalities may be linked to distinct decision-
making defects predisposing one toward the development of 
addictive behavior.
Conclusion and future directions
The goal of this paper has been to explore whether the 
SMH is applicable as a unifying explanatory framework of 
decision-making defects observed across different addic-
tions, and whether the evidence supports somatic marker 
functioning as a predisposing factor for the development of 
addiction. The SMH is a neuroanatomical and neurocogni-
tive decision-making framework that developed from studies 
of the decision-making defects that follow damage to the 
vmPFC. The impetus for the application of this framework 
in addiction research was the observation of comparable 
self-regulatory deficits between addicts and vmPFC patients, 
suggesting a common underlying mechanism.7
The SMH outlines a distinct neural architecture for its 
predictions, comprising a reflective system involved in self-
regulatory functions permitting the pursuit of long-term 
goals and the weighing of consequences, an impulsive system 
that engenders motivational states in relation to emotionally 
salient stimuli, and a homeostatic system involved in adapting 
behavior to the condition of somatic systems. A predisposi-
tion to addiction could result from dysfunction in either one 
or a combination of these three systems.65 Indeed, there is 
substantial evidence that addiction to both substances and 
behaviors are characterized by morphological anomalies and 
abnormal activation patterns in the neural regions outlined by 
the SMH.83,85,88,93,98,102,111,112,119 Furthermore,  preliminary evi-
dence suggests that subtle abnormalities might predate the 
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addiction as a diathesis for addiction development,152 and that 
these deficits can be accelerated by the use of psychoactive 
agents.148
The SMH states that the various neural components 
involved in the somatic marker system achieve adaptive 
decision making through an affective forecasting func-
tion that engenders somatic state activation in relation to 
option–outcome pairs.12 Studies of decision making in 
addiction have implied that addiction is characterized by 
a failure to engender appropriate somatic markers, which 
may represent a causal factor for the self-regulatory failures 
that characterize addiction. However, while dysfunctional 
decision making has consistently been observed in samples 
of drug and gambling addicts,22,135 the evidence regarding 
affective decision-making functions in Internet addiction 
is mixed.139–142 However, it is notable that the studies which 
did not find defective decision-making performance used 
inclusion criteria that are likely to result in a large number of 
participants that may not be regarded as true addicts. Future 
studies should aim to capture samples that are character-
ized by the core aspect of addiction – namely, persistent 
use despite increasing negative consequences. Moreover, 
previous studies have not investigated somatic state activa-
tion during task performance in Internet addiction. Thus, 
future studies could employ psychophysiological measures 
to investigate the notion of somatic marker failure in Internet 
addiction.
Both neuroanatomical abnormalities and decision-making 
defects have been shown to be predictive of substance use 
in adolescent samples.150,153 This implicates variations in 
somatic marker functioning as a predisposing factor, possibly 
implying that somatic marker defects could be an addiction 
endophenotype, promoting decision making that is both 
impulsive and compulsive. It follows from this suggestion 
that functional variations in the somatic marker system have 
a substantial genetic component, possibly related to genes 
encoding the efficiency of several interacting neurotransmit-
ter systems. The serotonin system has been widely implicated 
in affective decision making,46,49,56 as well as in addiction 
development and maintenance.47,155 This suggests that genetic 
variations affecting the efficiency of the serotonergic sys-
tem could be a central component in addiction risk through 
somatic marker failure. Longitudinal studies into the effects 
of polymorphisms implicated in serotonergic efficiency on 
decision-making capabilities and addiction proneness could 
be valuable in establishing the validity of this suggestion. 
Moreover, longitudinal studies could be instrumental in 
uncovering whether variations in somatic marker efficiency, 
operationalized as affective decision-making performance 
and somatic state activation, are related to different prog-
nostic features in addiction populations.
In sum, the somatic marker model of addiction pro-
vides a plausible account of how emotion-related signals 
generated by immediate and future prospects can bias 
addicts toward addiction development and maintenance. 
Both neuroanatomical and behavioral predictions derived 
from the framework have the potential to further advance 
the current knowledge of how deficient decision making 
contributes to addiction. However, the model has some 
limitations. Foremost is an uncertainty of how to best test 
its predictions regarding decision-making performance. 
While the IGT has been the paradigm most associated with 
the framework, it has been criticized for being cognitively 
penetrable143 and possibly driven by other psychological 
mechanisms (eg, reversal learning156). Thus, it remains 
uncertain whether the IGT actually measures affective 
decision-making performance or some other construct. 
Furthermore, the interpretation of the psychophysiologi-
cal changes (eg, SCR) preceding disadvantageous card 
selections on the task as reflecting somatic markers has 
been challenged.15 Therefore, an avenue for future research 
into the SMH in general and the somatic marker model 
of addiction would be to generate other paradigms that 
eliminate these uncertainties.
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